Summary
A rat brain tumor model has been developed with the clinical and pathological features of dissemination via the cerebral spinal fluid (CSF) pathways. A precise number of 9L gliosarcoma cells (5 × 102 to 5 × 105) is stereotactically injected into the CSF of the lateral ventricle. The interval until the onset of neurological symptoms and then death is reproducible and dependent upon the number of cells injected. The median survival of three groups of rats receiving 5 × 105 cells in three different experiments was 17, 18 and 19 days respectively. For three groups receiving 5 × 104 cells, the median survival was 23, 24 and 25.5 days respectively and for two groups receiving 5 × 103 cells the median survival was 28 and 30 days respectively. The animals developed multiple tumor implants along the CSF pathways usually resulting in hydrocephalus. This tumor model was developed to simulate dissemination via CSF pathways as seen with medulloblastoma and other primitive neuroectodermal tumors of the central nervous system. It will be used to evaluate the therapeutic efficacy of intra-ventricularly administered anti-neoplastic drugs against small implants and malignant cells in the CSF pathways.
Similar content being viewed by others
References
Auer RN, Del Maestro RF, Anderson R: A simple and reproducible experimental in vivo glioma model. Can J Neuro Sciences 8: 325–331, 1981
Ausman JI, Shapiro WR, Rail DP: Studies on the chemotherapy of experimental brain tumors: Development of an experimental model. Cancer Res 30: 2394–2400, 1970
Houchens DP, Ovejera AA, Riblet SM, Slagel DE: Human brain tumor xenografts in nude mice as a chemotherapy model. Eur J Cancer Clin Oncol 19: 799–805, 1983
Kaye AH, Morstyn G, Gardner I, Pyke K: Development of a xenograft glioma model in mouse brain. Cancer Res 46: 1367–1373, 1986
Kobayashi N, Allen N, Clendenon NR, Ko LW: An improved rat brain-tumor model. J Neurosurg 53: 808–815, 1980
Rosenblum ML, Gerosa MA, Dougherty DV, Wilson CB: Improved treatment of a brain-tumor model. Part I: Advantages of single-over multiple-dose BCNU schedules. J Neurosurg 58: 177–182, 1983
Saris SC, Bigner SH, Bigner DD: Intracerebral transplantation of a human glioma line in immunosuppressed rats. J Neurosurg 60: 582–588, 1984
Scheinberg LC, Suzuki K, Edelman F, Davidoff LM: Studies in immunization against a transplantable cerebral mouse glioma. J Neurosurg 20: 312–317, 1963
Schold SC, Rawlings CE, Bigner SH, Bigner DD: Intracerebral growth of a human glioma tumor line in athymic mice and treatment with procarbazine, 1,3-Bis(2-chlorethyl)-1-nitrosourea, Aziridinylbenzoquinone, and cis-Platinum. Neurosurg 12: 672–677, 1983
Shapiro WR, Basler GA, Chernik NL, Posner JB: Human brain tumor transplantation into nude mice. J Natl Cancer Inst 62: 447–453, 1979
Schold SC, Bigner DD: Treatment of five subcutaneous human glioma tumor lines in athymic mice with carmustine, procarbazine and mithramycin. Can Treat Rep 67: 811–918, 1983
Soloway AH, Mark VH, Dukat EG, Kjellberg RN: Chemotherapy of brain tumors: 1. Transplanted murine ependymoblastomas. Cancer Chemother Rep 36: 1–4, 1964
Chirigos MA, Humphreys SR, Goldin A: Effectiveness of cytoxan against intracerebrally and subcutaneously inoculated mouse lymphoid leukemia L1210. Cancer Res 22: 187–195, 1962
Perk K, Pearson JW, Torgerson JA, Chirigos MA: An animal model for meningeal leukemia. Int J Cancer 13: 863–866, 1974
Thomas LB, Chirigos MA, Humphreys SR, Goldin A: Development of meningeal leukemia (L1210) during treatment of subcutaneously inoculated mice with methotrexate. Cancer 17: 352–360, 1964
Thomas LB, Chirigos MA, Humphreys SRA, Goldin A: Pathology of the spread of L1210 leukemia in the central nervous system of mice and effect of treatment with cytoxan. J Nat Cancer Inst 28: 1355–1389, 1962
Rosso R, Donelli MG, Innocenti IR, Garattini S: Chemotherapy of tumors transplanted intracerebrally. Europ J Cancer 3: 125–137, 1967
Ushio Y, Chernik NL, Posner JB, Shapiro WR: Meningeal carcinomatosis: Development of an experimental model. J Neuropathy & Exp Neurology 36: 228–244, 1977
Schmidek HH, Nielson SL, Schiller AL, Messer J: Morphological studies of rat brain tumors induced by N-nitrosomethylurea. J Neurosurg 34: 335–340, 1971
Wheeler KT, Barker M, Wallen CA, Kimler BF, Henderson SD: Evaluation of 91_ as a brain tumor model. In: Sridhar R (ed) Methods in tumor biology: Tissue culture and animal tumor models. In press
Pellegrino LJ, Pellegrino AS, Cushman AJ: A stereotaxic atlas of the rat brain. 2nd Ed. Plenum Press, New York, 1979
Finger S, Frommer GP: Effects of somatosensory thalamic and cortical lesions on roughness discrimination in the albino rat. Physiol Behav 3: 83–90, 1968
Lee E, Desu M: A computer program for comparing k samples with right-censored data. Comp Prog Biomed 2: 315–321, 1972
Barker M, Hoshino T, Gurcay O, Wilsen CB, Nielson SL, Downie R, Eliason J: Development of an animal brain tumor model and its response to therapy with 1, 3-Bis(2-chloroethyl)-1-nitrosourea. Cancer Res 33: 976–986, 1973
Fulton JF: Physiology of the nervous system. ed 3, Oxford, New York, 1949
Deutsch M: Medulloblastoma: Staging and Treatment Outcome. Int J Radiat Oncol Biol Phys 14: 1103–1107, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rewers, A.B., Redgate, E.S., Deutsch, M. et al. A new rat brain tumor model: Glioma disseminated via the cerebral spinal fluid pathways. J Neuro-Oncol 8, 213–219 (1990). https://doi.org/10.1007/BF00177354
Issue Date:
DOI: https://doi.org/10.1007/BF00177354